Searched for
PATIENT ACCESS PROGRAM
Just donate blood and get VIP into famous temple. The result is blood bank surplus at local hospitalsA unique program in Madhya Pradesh connects blood donation with VIP darshan at Omkareshwar Jyotirlinga temple. Devotees donating blood rece...
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
The spy who hired me: Chinese agents hunt for secrets on LinkedInChinese intelligence is now using professional networking sites and job portals to find and recruit people with access to sensitive data. T...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Quote of the day by Princess Diana: 'Family is the most important thing in the world.' Life lessons on human behavior, peace, relationships and love by former princess of WalesQuote of the day by Princess Diana highlights the value of family, relationships, love, peace, and emotional support. Princess Diana believ...
Iran rejects Rubio's claims, blames US sanctions for global energy crisisUS-Iran war: Tehran has rejected remarks by US Secretary of State Marco Rubio. Iran states US sanctions have held the global energy market ...
Vice President Vance defers $1.3 billion in Medicaid funds to California, citing fraud concernsUS Vice President JD Vance announced a significant deferral of federal Medicaid funds to California. The government is withholding $1.3 bil...
Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vialEli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...
Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...
No gym, no equipment, no sweat: This 800-year-old Chinese exercise is quietly fixing high blood pressureAn 800-year-old Chinese exercise once practiced quietly in parks and public squares is now drawing global attention after scientists discov...
Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
Researchers develop sustainable method to boost active vitamin B12 in SpirulinaA scientific breakthrough offers a new way to produce vitamin B12. Researchers are using managed light on Spirulina, a blue-green algae. Th...
Prediction markets say they're different from sportsbooks. Gambling addicts say it's all the sameThe soccer coach had blocked himself from sportsbooks by the time he found prediction markets.
Has Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock MarketCannabis decision by the Federal Government Iargely legitimizes medical marijuana programs in the 40 states that have adopted them.
India’s growth engine is quietly powered by disciplined MSMEs, says Stanford Seed’s Harish ArnezathIndia's economic growth is increasingly driven by disciplined MSMEs, not just startups. Stanford Seed's Harish Arnezath highlights that fou...
Sun Pharma launches Imatinib Mesylate, incentives to US leukemia patientsDrug maker Sun Pharmaceuticals launched Imatinib Mesylate, the generic copy of anti-cancer drug Gleevec, in the US market enjoying 180 days...
Supreme Court's Glivec ruling will ruin innovation, says Ranjit Shahani, Novartis India MDToday’s Supreme Court judgment on the Glivec case means that innovator companies like Novartis will see little protection for intellectual ...